Skip to main content
Larry Cripe, MD, Oncology, Indianapolis, IN

Larry D Cripe MD


Associate Professor, Medicine, Indiana University School of Medicine

Join to View Full Profile
  • 535 Barnhill Dr# ROUTE473Indianapolis, IN 46202

  • Phone+1 317-278-1186

  • Fax+1 317-944-2181

Dr. Cripe is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Hematology and Medical Oncology, 1987 - 1990
  • Rush University Medical Center
    Rush University Medical CenterResidency, Internal Medicine, 1984 - 1987
  • Rush Medical College of Rush University Medical Center
    Rush Medical College of Rush University Medical CenterClass of 1984

Certifications & Licensure

  • IN State Medical License
    IN State Medical License 1995 - 2025
  • NC State Medical License
    NC State Medical License 1987 - 1998
  • MI State Medical License
    MI State Medical License 1993 - 1997
  • IL State Medical License
    IL State Medical License 1985 - 1987
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Indianapolis Monthly Castle Connolly, 2013
  • Top MD Consumers Checkbook

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Allogeneic Hematopoietic Cell Transplantation (HCT) Vs. Non-HCT Consolidation Therapies in Acute Myeloid Leukemia (AML) Patients 60-75 Years of Age in First Complete R... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • NCCN Awards Grants to Improve Care for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    NCCN Awards Grants to Improve Care for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaDecember 4th, 2024
  • Chuckstrong Tailgate Gala Raises More Than $2 Million, Marking a Decade of Dedication to IU Cancer Research
    Chuckstrong Tailgate Gala Raises More Than $2 Million, Marking a Decade of Dedication to IU Cancer ResearchAugust 5th, 2022
  • Cancer Interrupted Campus ‘Dad’s Weekend’ for Devoted Father
    Cancer Interrupted Campus ‘Dad’s Weekend’ for Devoted FatherOctober 3rd, 2021
  • Join now to see all

Grant Support

  • Single-Center Phase I Study To Determine The Optimal Biologic Dose Of Cc-401National Center For Research Resources2007–2008
  • Zosuquidar Trihydrochloride During Conventional Induction And Post-RemissionNational Center For Research Resources2006
  • Clinical Research OfficeNational Cancer Institute2004
  • Ly335979, Daunorubicin, Cytarabine In Myelogenous LeukemNational Center For Research Resources2000–2002

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: